
The U.S. Supreme Court on Thursday overturned a landmark settlement involving Purdue Pharma, marking a significant setback for efforts to resolve claims related to the opioid crisis. According to NBC News, the ruling dealt a blow to Purdue Pharma's bankruptcy reorganization plan, which aimed to allocate billions of dollars to victims of opioid addiction while shielding the Sackler family from future lawsuits.
The justices, voting 5-4, determined that the bankruptcy court had exceeded its authority by granting legal immunity to the Sacklers, who owned Purdue Pharma. This decision jeopardizes billions of dollars earmarked for compensating victims of the opioid epidemic.